Affordable bioprinting: tissue at the touch of a button

Modified 3D printer from the electronics store prints living tissue

23-Sep-2024 - Researchers have now succeeded in modifying a simple 3D printer so that it can create biological structures at the touch of a button. This is an opportunity for small laboratories to conduct research in this area too. "Tissue engineering is a technology of the future," Benedikt Kaufmann is ...

Sartorius and Science magazine to award prize for regenerative medicine and cell therapy

28-Jun-2017 - Sartorius together with the Science magazine will award a Sartorius & Science Prize for Regenerative Medicine & Cell Therapy. This prestigious annual award is geared towards exceptional scientists who focus on achieving advancements in basic or translational research in these areas. All ...

3D bioprinting technology: BASF and Poietis sign a research and development agreement

14-Jul-2015 - BASF and Poietis have signed an agreement on research and development in cosmetics. Based on the combined expertise of both companies in tissue engineering and bioprinting, the agreement aims to apply the bioprinting technology of Poietis to improve BASF’s skin equivalent model Mimeskin™. The ...

InnoCyte GmbH Finds Further Investors

26-Nov-2012 - InnoCyte GmbH has won three renowned investors for their cause: In a first round of financing, High-Tech Gründerfonds (HTGF), the Mittelständische Beteiligungsgesellschaft (MBG) – within the framework of the Seedfonds Baden-Württemberg – and Fraunhofer Venture have increased the capital of the ...

BIOTECHNICA 2010 with new focus topics

21-Sep-2010 - BIOTECHNICA 2010 is open for business in Hannover from 5 to 7 October, with new focus topics and more wide-ranging coverage. Europe’s leading biotech and life sciences event focuses on biotech applications in the fields of medicine, pharmaceuticals, food, agriculture, manufacturing industry and ...

t2cure First Company to Have Quality of Cellular Therapeutic Certified by European Medicines Agency

27-May-2010 - t2cure GmbH announced that the quality of its lead product t2c001 has been certified by the European Medicines Agency. t2c001 is the first product ever to obtain a certificate under the EMA regulations for Advanced Therapy Medicinal Products (ATMPs). It is a somatic cell therapy product derived ...